Expertise in
6
conditions

Melanie D. Beaton

London, ON, CA 
Expertise in
6
conditions
London, ON, CA 

Overview

Melanie Beaton practices practicing medicine in London, Canada.

Ms. Beaton is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Viral Gastroenteritis, Hemorrhagic Proctocolitis, Endoscopy, and Colonoscopy.

She is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

London, ON, Canada
Other Locations
Vancouver, BC, Canada
ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2026
Intervention Type: Other
Study Drug: Aminosalicylate
Study Phase: Phase 4
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2026
Intervention Type: Biological
Study Drug: Vedolizumab
Study Phase: Phase 4
View 1 Less Clinical Trial

51 Total Publications

TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
Journal: Pharmacogenetics and genomics
Published: April 21, 2026

Frequently Asked Questions about Melanie D. Beaton

Is Melanie D. Beaton a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Melanie D. Beaton is classified as an Distinguished expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Melanie D. Beaton participate in research or clinical trials?

Yes. Melanie D. Beaton has published 51 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Melanie D. Beaton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Beaton's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile